000 02258nam  2200361za 4500
0019.838151
003CaOODSP
00520221107151318
007cr |||||||||||
008170613s2017    onc     ob   f000 0 eng d
022 |z1925-0878
040 |aCaOODSP|beng
043 |an-cn---
0861 |aH113-9/2017-9E-PDF|zH113-8/2017-9E-PDF|zH113-8/2017-9E
24500|aIndaziflam |h[electronic resource].
260 |aOttawa : |bPest Management Regulatory Agency, Health Canada, |c2017.
300 |a46 p.
4901 |aProposed registration decision, |x1925-0886 ; |vPRD2017-09
500 |aIssued also in French under title: Indaziflame.
500 |aCover title.
500 |a"6 June 2017.”
500 |aIncorrect catalogue numbers (H113-8/2017-9E-PDF, H113-8/2017-9E) printed in this publication.
504 |aIncludes bibliographical references.
520 |a"Health Canada’s Pest Management Regulatory Agency (PMRA), under the authority of the Pest Control Products Act and Regulations, is proposing full registration for the sale and use of Indaziflam Technical Herbicide, Specticle SC and Specticle G, containing the technical grade active ingredient indaziflam, to control or suppress annual grasses and broadleaf weeds in field grown and container grown ornamentals. An evaluation of available scientific information found that, under the approved conditions of use, the product has value and does not present an unacceptable risk to human health or the environment. This Overview describes the key points of the evaluation, while the Science Evaluation provides detailed technical information on the human health, environmental and value assessments of Indaziflam Technical Herbicide, Specticle SC and Specticle G”--Overview, p. 1.
530 |aIssued also in print format.
69207|2gccst|aHerbicides
69207|2gccst|aCertification
69207|2gccst|aToxicology
7101 |aCanada. |bHealth Canada.
7101 |aCanada. |bPest Management Regulatory Agency.
77508|tIndaziflame |w(CaOODSP)9.838152
830#0|aProposed registration decision,|x1925-0886 ; |vPRD2017-09|w(CaOODSP)9.504464
85640|qPDF|s448 KB|uhttps://publications.gc.ca/collections/collection_2017/sc-hc/H113-9/H113-9-2017-9-eng.pdf